Ordenar

Buscar

01/03/2026 GRADE Guidance: Update on Developing Good Practice Statements in Guidelines
Dewidar, O, Akl, EA, Morgano, GP, Parmelli, E, Saz-Parkinson, Z, Langendam, MW, Meerpohl, JJ, Marti, M, Mayer, M, Djulbegovic, B, Brignardello-Petersen, R, Chu, DK, Murad, MH, Canelo-Aybar, C, Mathew, JL, Alonso-Coello, P, Qaseem, A, Schwingshackl, L, Bognanni, A, Rojas-Reyes, MX, Morgan, RL, Klugar, M, Comas, DR, Stallings, E, Iorio, A, Tugwell, P, Darzi, A, Turgeon, AF, Shamliyan, TA, Munn, Z, Mathioudakis, AG, Piggott, T, Lotfi, T, Pottie, K, Guyatt, G, Schünemann, HJ. GRADE Guidance: Update on Developing Good Practice Statements in Guidelines. ANNALS OF INTERNAL MEDICINE. 2026; 179(3)DOI:10.7326/ANNALS-25-00431. PMID:41554128. IF:15.200(Q1/1D).
01/03/2026 Impact of matrix-construction assumptions on quantitative overlap assessment in overviews: A meta-research study
Bracchiglione, J, Meza, N, Pieper, D, Lunny, C, Vargas-Peirano, M, Vicuña, J, Briceño, F, Parra, RG, Carrasco, IP, Urrútia, G, Bonfill, X, Madrid, E. Impact of matrix-construction assumptions on quantitative overlap assessment in overviews: A meta-research study. Research Synthesis Methods. 2026; 17(2)DOI:10.1017/rsm.2025.10056. PMID:41635949. IF:6.100(Q1/1D).
01/03/2026 Integrating planetary health considerations into health guidelines: decision-making bodies must show leadership
Metzendorf, MI, Aloosh, M, Benton, L, Perez, JB, Cumpston, M, de'Donato, FK, Laot, S, Piggott, T, Rahman, KMSU, Stein, AT. Integrating planetary health considerations into health guidelines: decision-making bodies must show leadership. Bmj Leader. 2026; 10(1)DOI:10.1136/leader-2025-001277. PMID:40730455. IF:(Q/D).
01/03/2026 Screening for lung cancer: A systematic review of overdiagnosis and its implications
Fernández-Sáenz, FK, de la Torre-Perez, L, Baldwin, DR, van der Aalst, C, Thorat, M, Ritchie, D, Carvalho, AL, Espina, C, Solà, I, Canelo-Aybar, C, Pissinis, MM, Alonso-Coello, P, Pinto, ACPN. Screening for lung cancer: A systematic review of overdiagnosis and its implications. Molecular Oncology. 2026; 20(3)DOI:10.1002/1878-0261.70139. PMID:41220098. IF:4.500(Q2/3D).